Source: Eur Respir J , 49 (2) 1602514; DOI: 10.1183/13993003.02514-2016



Rating:

Share or cite this content

Citations should be made in the following way:
Claudia E. Kuehni, Myrofora Goutaki, Helene E. Kobbernagel. Hypertonic saline in patients with primary ciliary dyskinesia: on the road to evidence-based treatment for a rare lung disease. Eur Respir J , 49 (2) 1602514; DOI: 10.1183/13993003.02514-2016

Member's Comments

No comment yet.

Related content which might interest you: Management of primary ciliary dyskinesia in European children: recommendations and clinical practice Source: Eur Respir J 2012; 39: 1482-1491 Year: 2012 Effectiveness of nebulised hypertonic saline on the respiratory management of children and young people with neuromuscular disease Source: International Congress 2019 – Innovations in care for chronic respiratory conditions Year: 2019 Impaired childhood growth velocity in patients with primary ciliary dyskinesia Source: Annual Congress 2013 –Paediatric respiratory epidemiology: new understandings of lung function, disorders of prematurity and chronic airway diseases Year: 2013 Primary ciliary dyskinesia as a cause of chronic suppurative lung disease in Turkish children Source: Eur Respir J 2003; 22: Suppl. 45, 316s Year: 2003 Primary ciliary dyskinesia in patients with recurrent pulmonary symptoms Source: Annual Congress 2004 - Chronic respiratory illness in childhood Year: 2004 Diagnosing primary ciliary dyskinesia: an international patient perspective Source: Eur Respir J 2016; 48: 1096-1107 Year: 2016 Clinical characteristics and follow up in adult patients with primary ciliary dyskinesia Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 Factors influencing age at diagnosis of primary ciliary dyskinesia in European children Source: Eur Respir J 2010; 36: 1248-1258 Year: 2010 Impact of a rare respiratory diseases reference centre set-up on primary ciliary dyskinesia care pathway Source: Eur Respir J, 59 (1) 2102413; 10.1183/13993003.02413-2021 Year: 2022 Pulmonary exacerbations in patients with primary ciliary dyskinesia: an expert consensus definition for use in clinical trials Source: ERJ Open Res, 5 (1) 00147-2018; 10.1183/23120541.00147-2018 Year: 2019 Access to medicines for rare diseases: beating the drum for primary ciliary dyskinesia Source: ERJ Open Res, 6 (3) 00377-2020; 10.1183/23120541.00377-2020 Year: 2020 Primary ciliary dyskinesia: early diagnosis and impact on lung function Source: Eur Respir J 2006; 28: Suppl. 50, 495s Year: 2006 The management of GERD in patients with advanced lung disease: drugs or surgery? Source: Annual Congress 2009 - The role of gastro-oesophageal reflux in advanced lung disease Year: 2009 Intervention trials and ventilation distribution in mild cystic fibrosis lung disease: will it all come out in the wash? Source: Eur Respir J 2011; 37: 757-759 Year: 2011 A pediatric case of CCNO associated congenital mucociliary disease – A novel entity in primary ciliary dyskinesia Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016 Is there a secondary defect in CFTR in the nasal epithelium of patients with primary ciliary dyskinesia? Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair Year: 2016 Characteristics of adults with primary ciliary dyskinesia in a bronchiectasis referral clinic Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Effectiveness and safety of hypertonic saline inhalation combined with exercise training in patients with chronic obstructive pulmonary disease: a randomized trial Source: Annual Congress 2009 - Improving outcome through exercise training or physiotherapy interventions Year: 2009 Lung function in primary ciliary dyskinesia: breaking the myth that this is a mild disease Source: Eur Respir J, 52 (2) 1801365; 10.1183/13993003.01365-2018 Year: 2018 The management of children with interstitial lung disease Source: International Congress 2018 – Difficult paediatric lung disease Year: 2018